rhG-CSF is associated with an increased risk of metastasis in NSCLC patients following postoperative chemotherapy

rhG-CSF is associated with an increased risk of metastasis in NSCLC patients following postoperative chemotherapy

BACKGROUND: Recombinant human granulocyte colony-stimulating factor (rhG-CSF) reduces neutropenia events and is widely used in cancer patients receiving chemotherapy. However, the effects of rhG-CSF on distant organ metastasis (DOM) in non-small-cell lung cancer (NSCLC) patients following postoperat...

Full description

Bibliographic Details
Main Authors: Chen, L. (Author), Chen, R. (Author), Fang, C. (Author), Fu, B. (Author), Li, Y. (Author), Qian, X. (Author), Qiu, X. (Author), Song, X. (Author), Wang, Q. (Author), Wang, Y. (Author), Xiao, Z. (Author), Yuan, S. (Author), Zhang, X. (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Subjects:
Distant organ metastasis (DOM)
Metastasis
Non-small-cell lung cancer (NSCLC)
Postoperative chemotherapy
Recombinant human granulocyte colony-stimulating factor (rhG-CSF)
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items